Alliança Saúde e Participações Past Earnings Performance
Past criteria checks 0/6
Alliança Saúde e Participações's earnings have been declining at an average annual rate of -61%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 2.3% per year.
Key information
-61.0%
Earnings growth rate
-61.0%
EPS growth rate
| Healthcare Industry Growth | 11.6% |
| Revenue growth rate | 2.3% |
| Return on equity | -23.2% |
| Net Margin | -19.3% |
| Next Earnings Update | 15 May 2024 |
Recent past performance updates
Recent updates
What Alliança Saúde e Participações S.A.'s (BVMF:AALR3) 26% Share Price Gain Is Not Telling You
Apr 17
Centro de Imagem Diagnósticos (BVMF:AALR3) Will Be Hoping To Turn Its Returns On Capital Around
Aug 17Why Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Could Be Worth Watching
Jul 08Is Centro de Imagem Diagnósticos (BVMF:AALR3) Using Too Much Debt?
May 28What Is Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Doing?
Apr 05Reflecting on Centro de Imagem Diagnósticos' (BVMF:AALR3) Share Price Returns Over The Last Three Years
Mar 10Should You Buy Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) For Its Dividend?
Feb 17What Percentage Of Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Shares Do Insiders Own?
Jan 27
Would Centro de Imagem Diagnósticos (BVMF:AALR3) Be Better Off With Less Debt?
Jan 06What Does Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Share Price Indicate?
Dec 11Centro de Imagem Diagnósticos S.A. (BVMF:AALR3) Is Yielding 0.8% - But Is It A Buy?
Aug 07Centro de Imagem Diagnósticos S.A.'s (BVMF:AALR3) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Jul 20Is Centro de Imagem Diagnósticos (BVMF:AALR3) Likely To Turn Things Around?
Jul 03Revenue & Expenses BreakdownBeta
How Alliança Saúde e Participações makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,180 | -228 | 325 | 0 |
| 30 Sep 23 | 1,154 | -263 | 326 | 0 |
| 30 Jun 23 | 1,132 | -287 | 345 | 0 |
| 31 Mar 23 | 1,100 | -247 | 340 | 0 |
| 31 Dec 22 | 1,085 | -228 | 338 | 0 |
| 30 Sep 22 | 1,092 | -135 | 304 | 0 |
| 30 Jun 22 | 1,110 | -55 | 281 | 0 |
| 31 Mar 22 | 1,127 | -32 | 280 | 0 |
| 31 Dec 21 | 1,137 | -6 | 262 | 0 |
| 30 Sep 21 | 1,160 | 38 | 238 | 0 |
| 30 Jun 21 | 1,121 | 29 | 213 | 0 |
| 31 Mar 21 | 978 | -66 | 188 | 0 |
| 31 Dec 20 | 929 | -97 | 172 | 0 |
| 30 Sep 20 | 898 | -103 | 168 | 0 |
| 30 Jun 20 | 915 | -84 | 167 | 0 |
| 31 Mar 20 | 1,047 | 10 | 164 | 0 |
| 31 Dec 19 | 1,073 | 41 | 159 | 0 |
| 30 Sep 19 | 1,069 | 50 | 159 | 0 |
| 30 Jun 19 | 1,073 | 47 | 163 | 0 |
| 31 Mar 19 | 1,076 | 43 | 171 | 0 |
| 31 Dec 18 | 1,077 | 40 | 176 | 0 |
| 30 Sep 18 | 1,074 | 10 | 185 | 0 |
| 30 Jun 18 | 1,087 | 9 | 195 | 0 |
| 31 Mar 18 | 1,082 | 8 | 204 | 0 |
| 31 Dec 17 | 1,078 | 7 | 216 | 0 |
| 30 Sep 17 | 1,081 | 36 | 242 | 0 |
| 30 Jun 17 | 1,042 | 26 | 252 | 0 |
| 31 Mar 17 | 1,015 | 13 | 263 | 0 |
| 31 Dec 16 | 951 | 15 | 257 | 0 |
| 30 Sep 16 | 874 | 27 | 238 | 0 |
| 30 Jun 16 | 806 | -3 | 223 | 0 |
| 31 Mar 16 | 734 | 56 | 192 | 0 |
| 31 Dec 15 | 700 | -13 | 183 | 0 |
| 31 Dec 14 | 393 | -4 | 101 | 0 |
| 31 Dec 13 | 276 | 28 | 80 | 0 |
Quality Earnings: AALR3 is currently unprofitable.
Growing Profit Margin: AALR3 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AALR3 is unprofitable, and losses have increased over the past 5 years at a rate of 61% per year.
Accelerating Growth: Unable to compare AALR3's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AALR3 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (38.6%).
Return on Equity
High ROE: AALR3 has a negative Return on Equity (-23.15%), as it is currently unprofitable.